Cephalexin Dosing for Breastfeeding Mothers with Mastitis
For a breastfeeding mother being treated for mastitis, the recommended cephalexin dose is 500 mg orally four times daily (every 6 hours) for 10-14 days, and breastfeeding should continue without interruption as cephalexin transfers minimally into breast milk.
Dosing Rationale
The standard adult dosing for cephalexin ranges from 1-4 grams daily in divided doses 1. For skin and soft tissue infections (which includes mastitis), 500 mg every 6 hours (four times daily) is the typical regimen 1. Some sources support 500 mg every 12 hours for certain infections, but the every-6-hour dosing provides more consistent coverage for staphylococcal and streptococcal organisms commonly implicated in mastitis 2, 3.
Safety During Breastfeeding
Cephalexin is safe during lactation and breastfeeding should continue without interruption. The evidence strongly supports this:
Minimal milk transfer: After a single 1-gram oral dose, peak milk concentrations averaged only 0.50 ± 0.23 mcg/mL at 4 hours 4. The FDA label confirms that cephalexin reaches a maximum level of 4 mcg/mL in breast milk after a 500 mg dose, then decreases gradually and disappears by 8 hours 1.
Low infant exposure: These concentrations are far below therapeutic levels and pose negligible risk to the nursing infant. The relative infant dose is well below the 10% threshold of concern 5.
Continued breastfeeding is therapeutic: For mastitis specifically, continued breastfeeding or milk expression from the affected breast is actually part of the treatment 3, 6, 7. Stopping breastfeeding can worsen mastitis and increase the risk of abscess formation.
Clinical Context for Mastitis Treatment
When to Start Antibiotics
Not all mastitis requires immediate antibiotics. A 1-2 day trial of conservative management (NSAIDs, ice application, continued breastfeeding, minimizing pumping) is often sufficient 6. Antibiotics should be initiated if:
- No improvement after 12-24 hours of conservative measures
- Severe symptoms at presentation
- Presence of a crack or fissure in the nipple
- Immunocompromised patient
Antibiotic Selection
Cephalexin (or other anti-staphylococcal agents like dicloxacillin) is first-line because Staphylococcus aureus is the most common causative organism (33% of cultured cases) 8. The drug provides coverage against both S. aureus and Streptococcus species 1, 3.
Alternative first-line agents include:
- Dicloxacillin 500 mg four times daily (also safe in breastfeeding with RID of only 0.03%) 9
- Flucloxacillin (used commonly in Australia) 8
Important Caveats
- Methicillin-resistant S. aureus (MRSA): If MRSA is suspected or confirmed (6% of S. aureus isolates in one audit) 8, consider trimethoprim-sulfamethoxazole or clindamycin instead
- Milk culture: Should be obtained when possible to guide therapy, especially if symptoms worsen or don't improve 6, 7
- Ultrasound: Consider if symptoms worsen, recur, or don't improve within 48-72 hours to rule out abscess 6
- Duration: Treat for 10-14 days to prevent recurrence 3, 6
What NOT to Do
Modern evidence has shifted away from older practices:
- Do not recommend aggressive breast massage - this can worsen inflammation 6
- Do not recommend heat application - may increase inflammation 6
- Do not recommend excessive pumping to "empty the breast" - this overstimulates milk production and worsens the condition 6
- Do not stop breastfeeding - this is contraindicated unless there is purulent drainage directly into the infant's mouth 10
The infant can safely continue nursing even during active mastitis treatment, as the antibiotics used are compatible with breastfeeding and the infection does not pose a risk to the infant 3, 7.